Derivatives: Adjustment in Karo Pharma due to righ
Post# of 301275
(Total Views: 30)
Posted On: 05/07/2018 1:00:32 PM
Derivatives: Adjustment in Karo Pharma due to rights issue (06/18)
The Annual General Meeting (AGM) of Karo Pharma AB (Karo Pharma) held on May 3, 2018, approved a rights issue whereby shareholders are entitled to one (1) new share for every two (2) shares held. The subscription price is SEK 24.00 per share. The Ex-date is May 8, 2018. NASDAQ Derivatives Markets has carried out a re-calculation of options, forwards and futures in Karo Pharma (KAROB).
For further information please find the attached file.
(0)
(0)Scroll down for more posts ▼